Account
Dentsu Webchutney wins digital & social media mandate for HealthKart
Mumbai: Dentsu Webchutney, the digital creative agency from the house of dentsu India, has been appointed as the digital and social media partner for the HealthKart brands- HK Vitals and bGreen.
HK Vitals and bGreen are private label brands that operate in their own niches within the online marketplace for health products. While HK Vitals is a nutrition and supplements brand, bGreen is a plant-based nutrition brand with products in both the performance nutrition category and active wellness nutrition category.
Dentsu Webchutney’s credentials and work for high-performing e-commerce brands helped the agency translate a one-project deal with HealthKart into this much deeper commitment as their digital and social media partner, the agency said.
Dentsu Webchutney CEO, Gautam Reghunath stated, “HealthKart is a pioneer in the Indian nutrition and wellness space and one that is vertically integrated into a fragmented category. It is a brand that’s constantly innovated through product excellence and delivering on consumer needs. There is so much evolution happening in the vitals and nutrition space and we are lucky to be partnering with HealthKart who is at the front of it all.”
HK Vitals/HealthKart AVP – brands, Kaustuv Paliwal added, “We are absolutely thrilled to be joining forces with Dentsu Webchutney. Partnering with them to lead our charter on digital marks the beginning of a journey that is filled with intent and backed by action.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
